Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |